Immunotherapy given during and after chemoradiation did not improve survival for study participants with limited-stage, small-cell lung cancer (SCLC) according to the results of an international ...

Immunotherapy given during and after chemoradiation did not improve survival for study participants with limited-stage, small-cell lung cancer (SCLC) according to the results of an international ...

Immunotherapy given during and after chemoradiation did not improve survival for study participants with limited-stage, small-cell lung cancer (SCLC ...

Alcohol-associated liver disease (ALD) remains a leading cause of cirrhosis and liver-related mortality worldwide, with few effective therapies.

Researchers are testing a radiation technique that compresses an entire cancer treatment dose into a fraction of a second, ...

Particle therapy experts gathered in London to discuss the transformative potential of laser-driven proton and ion beams ...

Protein aggregates as hallmarks of severe alcohol-related liver injuryAlcohol-associated liver disease (ALD) remains a leading cause of cirrhosis and ...

PYRUKYND is also approved for adults with PK deficiency in the U.S. and Europe, and a marketing application for PYRUKYND in thalassemia is currently under review by the European Commission. In the U.S ...

A weak result and a sudden CEO departure have left CSL shares at eight-year lows. Management says the recovery plan ... Read ...

Global carbon budgets attribute an incomplete role to cultivated plants due to the exclusion of annual crops, since they are not considered to result in net carbon accum ...